Overview
- 3 inspections across 3 sites are on record.
- 5 Form 483 observations are attributed to this investigator.
- Most recent recorded activity is 2020-03-05.
At a glance
Inspections
3
Sites
3
Observations
5
Career since
Jan 2018
Recent inspections
Most recent inspections in the published record.
| Site | Date | Category | Form 483 |
|---|---|---|---|
| Omrix Biopharmaceuticals Ltd. | 5 Mar 2020 | Biologics | View 483 → |
| OMRIX BIOPHARMACEUTICALS LTD | 24 Feb 2020 | Biologics | On file |
| Baxalta US Inc. | 19 Jan 2018 | Biologics | On file |
Sites inspected
Omrix Biopharmaceuticals Ltd.Nes-Ziona, Israel1 insp.
OMRIX BIOPHARMACEUTICALS LTDRamat Gan, Israel1 insp.
Baxalta US Inc.Thousand Oaks, United States1 insp.
Co-investigators
Investigators who share inspections with this person.
Steven E Bowen2 shared
Mihaly S Ligmond2 shared
Aikaterini Alexaki1 shared
Omotunde O Osunsanmi1 shared
Gene D Arcy1 shared
Full investigator report
Get the verbatim findings behind Chava Kimchi Sarfaty's 5 observations
Source 483 PDFs, verbatim observations, and how each site responded, so your team knows what they cite before they arrive.
- New inspections and Form 483s, mapped to the CFR citation
- Warning letter outcomes, and the citation patterns they repeat
- Their co-investigators, so no surprises about who shows up on site